- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-6958
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tailored therapy for severe asthma ; volume:10 ; number:1 ; day:16 ; month:1 ; year:2015 ; pages:1-8 ; date:12.2015
Multidisciplinary respiratory medicine ; 10, Heft 1 (16.1.2015), 1-8, 12.2015
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Menzella, Francesco
Lusuardi, Mirco
Galeone, Carla
Zucchi, Luigi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2049-6958-10-1
- URN
-
urn:nbn:de:101:1-2019061003070091414058
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Menzella, Francesco
- Lusuardi, Mirco
- Galeone, Carla
- Zucchi, Luigi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biological therapy for severe asthma
Severe Asthma and Biological Therapy: When, Which, and for Whom
Severe Asthma: Challenges and Precision Approaches to Therapy
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
Emerging therapies for severe asthma
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy
Biological therapy in severe asthma: A gem or a jam
Severe asthma in childhood
New drugs for asthma therapy
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
Biological therapy for severe asthma
Severe Asthma and Biological Therapy: When, Which, and for Whom
Severe Asthma: Challenges and Precision Approaches to Therapy
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
Emerging therapies for severe asthma
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy
Biological therapy in severe asthma: A gem or a jam
Severe asthma in childhood
New drugs for asthma therapy
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
Biological therapy for severe asthma
Severe Asthma and Biological Therapy: When, Which, and for Whom
Severe Asthma: Challenges and Precision Approaches to Therapy
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
Emerging therapies for severe asthma
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Confounders of severe asthma: diagnoses to consider when asthma symptoms persist despite optimal therapy
Biological therapy in severe asthma: A gem or a jam
Severe asthma in childhood
New drugs for asthma therapy
Characteristics of Severe Asthma Patients and Predictors of Asthma Control in the Swiss Severe Asthma Registry